We studied 20 individuals from 17 unrelated families with congenital dyserythropoietic anemia (type II; CDAII). The clinical phenotype was mild to moderate. The inheritance pattern was invariably recessive. Coomassie blue stained gels after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) show that band 3 was thinner and migrated slightly faster than usual. In addition, staining showed two unknown minor bands (in the patients), but not in normal controls, the obligate carrier parents, or in patients with other anemic syndromes. These minor proteins were studied using partial digestion, amino acid sequencing, Western blotting, immunofluorescence, and immunogold electron microscopy. They were identified as the glucose-ONGENITAL dyserythropoietic anemia (CDA) desig-C nates a group of genetic disorders in which erythropoiesis is ineffective. CDA (type I1 [CDAII]; also known as hereditary erythroblastic multinuclearity with positive acidified serum [HEMPAS] test) is the most common type of CDA. It is characterized by a recessive mode of inheritance, mild to moderate anemia, jaundice, and splenomegaly.',' Serologic and morphologic abnormalities include the persistence of a high i antigen activity, a positive Ham's test result, and a frequent binuclearity in late erythroblasts in the bone
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In addition, a particular feature of CDAII erythroblasts and erythrocytes is the presence of peripheral cisternae running parallel to and beneath the plasma membrane in a continuous or discontinuous f a~h i o n .~.~ The two adjacent membrane systems are often referred to as the double-membrane.
Numerous biochemical changes have been noted in circulating CDAII erythrocyte membranes. Band 3 glycoprotein is thinner and migrates slightly faster than in controls on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).7-'2 This apparent shift in molecular weight is related to deficient incorporation of lactosaminoglycans'3 and is associated with an abnormal clustering of band 3.14 On the other hand, glycolipids appear to be overgly~osylated.'~*'~ Defects in N-acetylglucosaminyltransferase, galactosyltransferase, and a-mannosidase I1 have been recorded in the white blood cells of CDAII patient^.".'^ However, the ultimate genetic lesion responsible for CDAII remains elusive.
We have identified three minor proteins present on Coomassie blue-stained gels of samples from CDAII red blood cell (RBC) ghosts: the glucose-regulated protein GRP78,20,21 c a l r e t i c~l i n ,~~-~~ and the protein disulfide isomerase (PDI):5 which are resident proteins of the endoplasmic reticulum (ER) lumen.26 Microscopic studies were performed with PDI. Immunofluorescence microscopy showed a colocalization, with the dense discontinuous ring decorating the plasma membrane. Immunogold electron microscopy showed that it occurred in the lumen of the cisternae running beneath the RBC membrane. regulated protein GRP78 and calreticulin that are resident proteins of the endoplasmic reticulum (ER). Using specific antibody, we showed that protein disulfide isomerase (PDI), a third major protein of the ER, was also present on the SDS-PAGE of red blood cell (RBC) ghosts. Immunofluorescence colocalized PDI with the dense discontinuous ring decorating the RBC membrane. lmmunogold electron microscopy showed that PDI was localized in the lumen of the cisternae, confirming that these originate from the smooth ER. From a practical point of view, screening the above minor proteins in RBC membranes appears to be a straighfforward and reliable diagnostic test for CDAII.
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CASE REPORTS
We investigated 20 CDAII patients from 17 unrelated families originating from France (1 family), Italy (13 families), and Spain (3 families; Table 1 ). In Italy, all but 1 of the probands resided in the southem part of the country. In most cases, anemia was diagnosed early in childhood based on classical criteria. The parents were clinically normal and presented with no detectable change in the RBC indices. The father, ROI.1, and the mother, ROI.2, of children ROII.1 and ROII.2 were also investigated biochemically as obligate CDAII carriers. We had no proof that consanguinity existed, although this was suspected in some families.
In addition to samples from normal individuals, we investigated samples from patients with CDAI" (unpublished data), hereditary spherocytosis (HS), and hereditary elliptocytosis (HE), respectively.
4434
ALLOlSlO ET AL t The initial diagnosis of CDAll in child PM11. 6 (1981) was based on the presence of the same clinical features as in her sisters, PM11.4 and PM11.5 (nonregenerative anemia, hypersideremia, and increased free bilirubin), and on the typical aspect of band 3 on SDS-PAGE." Bone marrow was not examined. In the present study, we found in this patient the three additional minor proteins (GRP78, PDI, and calreticulin) on SDS-PAGE and the double-membrane under optical and electronic microscopy.
Among the HS patients" (unpublished results), several displayed a reduction in band 3, as has been presented by other^.*^-^'
MATERIALS AND METHODS

Protein Chemistry
Erythrocyte ghost protein analysis was performed using SDS-PAGE according to L a e~n d i~~ (acrylamide concentration, 7%). Fifteen micrograms of protein, assayed using the Lowry procedure, was loaded in each lane. We verified that the surface area of all of the Coomassie blue-stained peaks was very similar for each sample. Peak areas of individual major proteins (spectrin, band 3 [see below], proteins 4.1 and 4.2, and actin) did not vary in the CDAII samples and thus could serve as references. The amount of band 3 was expressed with respect to each major membrane protein peak (aspectrin, protein 4.1, protein 4.2, and actin, but not P-spectrin and ankyrin, which comigrated on the Laemmli gels). The amounts of the 74-kD and the 58-kD proteins (see below) were expressed with respect to all membrane protein peaks. However, to improve the estimate, we subtracted the optical density of the corresponding area in the control samples. We also used 3.5% to 17% exponential gradient Fairbanks gels35 to determine the amount of band 3 relative to total spectrin.
After electrophoresis, the 74-and 58-kD proteins were electroblotted onto polyvinylidene fluoride (PVDF) membranes (Immobilon; Millipore/Continental Water Systems, Bedford, MA), cut out from the membranes, and microsequenced with an Applied Biosystems Model 470 A gas-phase sequenator (Model 470A; Applied Biosystems Inc, Foster City, CA) coupled on line with a PTH-amino acid analyzer (Applied Biosystems Inc), as previously described.'6 However, because we were unable to sequence the 74-!& protein (presumably due to blocked N-terminal residue), we performed in situ protease cleavage on the PVDF membrane, followed by peptide separation using reverse-phase high-performance liquid chromatography (HPLC).3' Specifically, tryptic digestion (trypsin-TPCK Worthington Biochemical Corp, Freehold, NJ) was performed for 6 hours at 37°C. The supematant and the five subsequent washing solutions (about 600 pL) were loaded on a C8 reverse-phase column (0.46 X 22 cm; Applied Biosystems Inc.), and the peptides were eluted with a linearly increasing gradient of acetonitrile in 0.05% trifluoroacetic acid. Peptides were selected for amino acid sequencing on the basis of peak height and resolution.
Amino acid sequence comparisons were performed using the FASTDB Computer program of Intelligenetics (Mountain View, CA). Two protein data bases were screened: the Protein Identification Resources (release 30) from the National Biochemical Research Foundation and the Genbank (release 70).
Western Blots
Western blots were performed after SDS-PAGE." Equivalent amounts of proteins (1 5 pg) were loaded on the gel for each sample. In addition, we assessed that equivalent amounts of proteins were transferred onto the nitrocellulose membrane using Ponceau S red staining by comparing the intensities of the invariant protein bands: spectrin, proteins 4.1 and 4.2, and actin. We used (1) a monoclonal Table 1 ).
antibody (dilution 11500) against a synthetic peptide o f rat GRP78
exhibiting cross-reactivity with human GRP78 and GRP94 (Stress 
Phase Contrast Microscopy
Red blood cells from a control and from a C D A l I patient (PMII. 6) were lysed using distilled water and examined using phase-contrast microscopy as previously described?
Immunoj71mrescence Microscopy
Red blood cells from a control and a C D A I I patient (PM11.6) were cytospun on a slide and fixed for 5 minutes using methanol. The monoclonal antibody against PDI, diluted at 11250, was incubated with the samples at room temperature for 30 minutes. After three washes i n phosphate-buffered saline (PRS), a fluorescein-conjugated antimouse IgG sheep Fab'? (Silenus. Hawthorn. Australia) was applied at a 11100 dilution for 30 minutes. After washing and mounting. cells were examined under a fluorescence microscope.
lmmrinogold Electron Microscopy
Normal and pathologic (from patient PM11.6) red hlood cells were prepared for immunogold electron microscopy by fixing them in 1%-glutaraldehyde in 0.1 mol/L phosphate huffer (PB), pH 7.4. for I hour at 22°C. washing them three times with the same buffer, embedding them in 1.5% polyvinylpyrrolidone (PVP: Sigma. St Louis, MO: 0.3 mmol/L PVP, 1.1 mol/L Na2C0,. 2 mol/L sucrose in PB), and freezing them i n liquid nitrogen.'" The immunochemical reactions were performed on ultra-thin sections collected on copper grids according to the method o f Slot et al."' Briefly. the sections were labeled by a first incubation with the monoclonal antibody against PDI used at 11500 dilution i n PRS containing 1% o f bovine serum 
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The data correspond to the partial amino acid sequences of the 74-and 58-kD components seen in CDAll samples. Question marks indicate Molecular weight as determined on our gels.
the positions at which residues could not be identified with certainty. Residues in parentheses are the most probable assignment.
For 7 .0, and methyl cellulose uranyl and samples were observed using a Philips CM 10 electron microscope (Philips, Eindhoven, The Netherlands). Some additional samples were prepared using a monoclonal antibody against band 3 (Sigma), which was diluted 1/50.
RESULTS
Protein Chemistry
The samples from all the patients with CDAII had a thinner band 3 than usual that also migrated slightly faster on SDS-PAGE, as has been previously reported'.'' (Fig 1) . Nonetheless, in agreement with a previous pubIication,l3 the amount of band 3, measured through Coomassie blue staining, was within the normal range (band 3/total spectrin ratio 1.08 2 0.09 [n = 201 v 1.10 2 0.07 in normal controls [n = 271). However, a recent report of two CDAII cases showed that band 3 was present in quantities ranging from 60% to 75% of norma1.4" In the CDA I sample, band 3 was qualitatively and quantitatively normal (data not shown). In the sample HS with band 3 deficiency, there was 20% to 40% less band 3, but the band retained its normal width and position on SDS-PAGE (data not ~h o w n ) .~' .~~ In all CDAII patients, two minor proteins of 74 and 58 kD were observed on Coomassie blue-stained gels (Fig 1) . The amount of these proteins represented 0.7% to I .7% (74-kD protein) and I % to 2% (58-kD protein) of the total normal membrane proteins. The 74-kD band was not present in normal controls; in CDAll obligate carriers (individuals RO 1.1 and RO 1.2); in patients presenting with CDAI, HS (with or without band 3 deficiency), and various cases of HE (data not shown). In all these individuals, a very faint 58-kD band could be seen; however, it did not react with anticalreticulin antibodies (see below and Fig 1) .
Amino acid sequencing of the N-terminal region of the 58-kD component and sequencing of several peptides obtained after partial digestion of the 7 4 4 3 component yielded the data presented in Table 2 . Homology searches showed that the 74-kD protein was the glucose-regulated protein referred to as GRW8." This protein belongs to the family of heat-shock proteins HSWO. The apparent molecular weight (74 kD) that we determined using SDS-PAGE was in good agreement with those reported previously and with the actual molecular weight of GRW8 (73 kD).2n.21.'h The 58-kD protein was calreticulin, a high-affinity Ca2' binding p r~t e i n . '~.~~ The molecular weight that we determined (58 kD) was substantially different from the actual molecular weight of the protein (48 kD). This aberrant electrophoretic mobility has been noted before and is attributed to the high acidic amino-acid content of calreticulin." Both GRP78 and calreticulin are major resident proteins of the ER lumen.
Western Blots
Culreticulin. Polyclonal antibodies against human calreticulin reacted strongly with CDAII samples but not with For personal use only. on July 15, 2017. by guest www.bloodjournal.org From normal samples (Fig I) . This reaction was observed with samples from all CDAII patients (Fig 2) , although the intensity of the response was variable. Two subgroups of patients emerged depending on whether splenectomy had been performed. Splenectomized patients yielded a stronger response than did nonsplenectomized patients. As shown below, calreticulin reflects the presence of cisternae of the ER. It may be assumed that the red blood cells that are the richest in ER were those most readily destroyed by the spleen. In the CDAII obligate carriers RO 1.1 and RO 1.2, the antibodies failed to show calreticulin (Fig 2) . This fact emphasizes the strictly recessive inheritance pattern of CDAII.
GRP78. Monoclonal antibody against rat GRP78 showed a strong band in CDAII samples but not in normal samples (Fig I) . A faint additional band was also shown in CDAII samples only. This band may correspond to GRP94, a third major protein of the ER lumen,'".'' based on its electrophoretic mobility and its cross-reactivity with the monoclonal antibody, as reported by the manufacturer (Stress Gen Biotechnologies Corp). A band migrating just above band 3 in CDAII patients could be seen on the Coomassie bluestained gels and this possibly corresponds to GRP94 ( Fig  I) . In controls, this region was blurred by the larger band 3, but we can expect that there is no band. Unexpectedly, the anti-GRP78 monoclonal antibody displayed a strong crossreaction with a-spectrin, although the manufacturer had not reported this; therefore, the possibility that the 94-kD band is a spectrin degradation product that, for an undetermined reason, is present in CDAll membranes and not in controls cannot be disregarded, although it sounds very unlikely.
Besides calreticulin and GRP78 (and GRP94), the ER contained another major protein, the PDI."."' Specific polyclonal antibodies against PDI showed a strong reaction with CDAII samples only (Fig I) . The measured molecular weight (59 kD) of the band is close to the actual molecular weight (57 kD) of PDI.*' This protein migrated just above calreticulin in our hands. As stated by the manufacturer, the monoclonal antibody against PDI cross-reacts with calreticulin (Fig I) . There was less PDI than calreticulin in Western blots, which may explain why only one band (calreticulin) was clearly seen on the Coomassie blue-stained gels.
Phase Contrast and ImmunoJluorescence Microscopy
In all normal red blood cell ghosts, the cell membrane had a uniform contrast. However, in CDAIl red blood cell ghosts, many cells exhibited a discontinuous peripheral dense ring that was often split into several fragments ( Fig  3A) , as has been reported previously. 4 The majority of CDAIl red blood cells were labeled using the anti-PDI monoclonal antibody and exhibited a discontinuous peripheral fluorescent ring, similar to the image seen with phase contrast. Some of them exhibited single fluorescent dots (Fig 3B) . This technique was more sensitive than the phasecontrast microscopy in that it detected very short ER residues. In the control, there was no labeling (not shown).
Immunogold Electron Microscopy
Using the anti-PDI monoclonal antibody, a strong and specific labeling was observed only in the lumen of the ER PDI. when dense material was preserved (Fig 3C) . No gold particles were seen where the lumen was clear, on the cell membrane, or between the latter and the ER. When the cisternae were dilated, dense material concentrated at one or both extremities and the labeling was restricted to these zones. In many red blood cells, one or two globular structures were heavily labeled (data not shown). They could correspond to the dense granules observed by phase contrast and to the dots seen by immunofluorescence. There was no specific labeling in the control.
Using an anti-band 3 antibody in CDAll red blood cells. a weak but specific labeling was present both in the cisternae of ER and in the cell membrane. This usually appeared to be close to the ER membrane or to the plasma membrane (data not shown).
DISCUSSION
We have detected three additional minor proteins that are all resident proteins of the ER lumen26 associated with CDAIl red blood cell membranes: GRW8,'".'' calreticulin,'?-'' and PDI." Using a variety of microscopic techniques, we showed that PDI is localized inside the cisternae of the ER, which are variable in shape and number and run parallel to and beneath the plasma membrane.'"' This provides formal evidence that the cisternae associated with CDAIl originate from the ER, as has been previously suggested."."
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From It was interesting that some band 3 molecules also appeared at the level of the cisternae membrane and the plasma membrane. The amount of normal band 3 determined using SDS-PAGE suggests that some band 3 molecules are retained in the ER instead of being incorporated in the plasma membrane. If this is so, purified plasma membrane would be expected to be deficient for band 3; further studies will be necessary to investigate this hypothesis.
It remains unclear how all the abnormal features recorded in CDAII can have a coherent explanation. The synthesis of polylactosaminoglycans increases significantly at the stage of erythroblast. Fukuda2 has suggested that defects in various glycosyltransferases or glycosidases could affect other glycoproteins besides band 3. Some glycoproteins may be involved in cytokinesis and/or the clearance of intracellular organelles, but no such glycoproteins has been identified.
CDAII is not a rare condition, but it can be wrongly diagnosed, because no easy reliable test exists for its diagnosis. We suggest that the altered characteristics of band 3 and the presence of GRP78, calreticulin, and PDI on SDS-PAGE may provide such a diagnostic tool in the future. The availability of antibodies against these three proteins would increase the accuracy of the diagnosis. These anomalies seem to be highly specific for CDAII, although we have not studied CDAIII.
We have shown that proteins of the ER (GRP78, calreticulin, and PDI) migrate with red blood cell membrane proteins in samples from CDAII patients on SDS-PAGE. PDI is located in the lumen of the cisternae that decorate the inner surface of the CDAII erythrocyte membrane. This provides strong evidence that the cisternae, reported a long time ago in CDAII patients, originate from the ER. 
